Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedCap ABCHIX:MCAPS 93 Days Inventory is 118.33 as of Mar. 2026, which is 9% below its 10-year median of 130.39. GuruFocus rates CHIX:MCAPS with a GF Score™ of 93/100 and a GF Value™ of kr596.05 (Fairly Valued). Among 787 Medical Devices & Instruments companies, MedCap AB ranks better than 72.68% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). MedCap AB's Average Total Inventories for the
three
months ended in Mar. 2026 was kr284 Mil. MedCap AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr219 Mil.
Hence, MedCap AB's Days Inventory for the
three
months ended in Mar. 2026 was 118.33.
The historical rank and industry rank for MedCap AB's Days Inventory or its related term are showing as below:
CHIX:MCAPs'
s Days Inventory Range Over the Past 10 Years
Min: 87.21 Med: 130.39 Max: 151.32
Current: 120.24
During the past 13 years, MedCap AB's highest Days Inventory was 151.32. The lowest was 87.21. And the median was 130.39.
CHIX:MCAPs's Days Inventory is ranked better than 72.68% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.47
vs CHIX:MCAPs: 120.24
MedCap AB's Days Inventory
declined
from Mar. 2025 (125.58) to Mar. 2026 (118.33).
Inventory Turnover measures how fast the company turns over its inventory within a year.
MedCap AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MedCap AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.51.
MedCap AB (CHIX:MCAPs) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
MedCap AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MedCap AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
MedCap AB Days Inventory Related Terms
MedCap AB Days Inventory Historical Data
* Premium members only.
The historical data trend for MedCap AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MCAPS vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, MedCap AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedCap AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where MedCap AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedCap AB (CHIX:MCAPS) has a Days Inventory of 118.33 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MedCap AB and its competitors. This is near median its historical median of 130.39. Over the past decade, MedCap AB's Days Inventory has ranged from 87.21 to 151.32. According to the industry distribution chart, MedCap AB ranks #215 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 27.3%.
Is MedCap AB's Days Inventory too high?
MedCap AB's current Days Inventory of 118.33 is near median its 10-year median of 130.39. Over the past 10 years, this metric has ranged from a low of 87.21 to a high of 151.32. The Medical Devices & Instruments industry median Days Inventory is 179.47. MedCap AB's value of 118.33 is 34.1% below this industry median. Based on the distribution chart, MedCap AB ranks #215 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, MedCap AB has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MedCap AB ranks #215 out of 787 companies for Days Inventory. This puts MedCap AB in the upper half of its industry. The industry median Days Inventory is 179.47. MedCap AB's value of 118.33 is 34.1% below this benchmark. Historically, MedCap AB's own Days Inventory has ranged from 87.21 to 151.32 over the past decade. While the company's 10-year median is 130.39 vs. the industry median of 179.47, MedCap AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.47, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedCap AB's current Days Inventory of 118.33 is 34.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on MedCap AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedCap AB's current Days Inventory is 118.33, which is near median its own 10-year median of 130.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (CHIX:MCAPS) is currently considered Fairly Valued. The stock's GF Value™ is kr596.05, compared to a current price of kr555.00 — trading 6.9% below its estimated fair value. The current Days Inventory is 118.33, which is near median its 10-year median of 130.39 and 34.1% below the Medical Devices & Instruments industry median of 179.47. MedCap AB's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For MedCap AB (CHIX:MCAPS), the current Days Inventory is 118.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedCap AB (CHIX:MCAPS) Overvalued in 2026?
Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued.
The current stock price of kr555.00 is trading 6.9% below its estimated GF Value™ of kr596.05.
GuruFocus considers MedCap AB to be Fairly Valued.
Key valuation signals for CHIX:MCAPS:
Days Inventory: 118.33 (near median its 10-year median of 130.39)
GF Value™: kr596.05 vs. price of kr555.00 (6.9% below fair value)
Industry Position: 34.1% below the Medical Devices & Instruments median (#215 of 787)
No single metric tells the full story. See the CHIX:MCAPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
93GF Score
Get the complete analysis for CHIX:MCAPS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MCAPS has been successfully added to your 
